To anyone else, it’s just a walk around the block. But for Frank Coburn, 57, and his wife, it’s a miracle. A miracle that resulted from Coburn becoming the first Southern Californian—and possibly first in the U.S.—to receive a minimally invasive double lung transplant. The procedure was performed at the Smidt Heart Institute.
New research from the Smidt Heart Institute shows that more patients—specifically those with medical risk factors or from underserved communities—opted into telehealth appointments for their cardiovascular care during the COVID-19 pandemic.
Dominic Emerson, MD, and Pedro Catarino, MD, both transplant surgeons with the Smidt Heart Institute, know how to be spontaneous. At any given moment, they can get the call that a donor heart or lungs are available, requiring them to quickly board a private aircraft to procure the vital organs.
Peter Chen, MD, remembers those early days of March 2020 as one of swirling hyperactivity in the intensive care unit he leads at Cedars-Sinai. Chen and his team were struggling to respond to an emerging health crisis that was quickly growing into a global pandemic.
Lisa Stewart doesn’t dwell on the fact that she might be the first in the nation to undergo both mitral and tricuspid valve replacement procedures. She’s too busy counting her blessings.
Healthcare workers might not be so different from the general population in the factors that determine their risk of getting COVID-19. A new study led by Cedars-Sinai shows that healthcare workers are more likely to have antibodies to COVID-19 in their blood if they are African American or Latino or have hypertension.
A new study from the Smidt Heart Institute at Cedars-Sinai shows that women have a lower “normal” blood pressure range compared to men. The findings were published today in the peer-reviewed journal Circulation.
Valentine’s Day is a little sweeter this year for first-time mother Donet Teimourian, 33, who gave birth to son Roman at Cedars-Sinai in September.
Medical science has come a long way in efficiently diagnosing and effectively treating women with heart disease, but with upward of 500,000 women in the U.S. being treated for it every year, there is more work ahead, says one of the nation’s leading experts.
When Shari Baugh, 61, woke up on her birthday last October, she had two new reasons to be grateful for another trip around the sun: the healthy heart and kidney she had just received from Cedars-Sinai transplant surgeons.
New research from the Center for Cardiac Arrest Prevention in the Smidt Heart Institute at Cedars-Sinai has found for the first time that during nighttime hours, women are more likely than men to suffer sudden death due to cardiac arrest. Findings were published in the journal Heart Rhythm.
Throughout the COVID-19 crisis, Cedars-Sinai employees have stepped-up and stepped-in to support patients and colleagues alike. And while there has been no shortage of selflessness, one group of volunteers shines a bright light on both the innovation and teamwork spurring from the past 10 months of treating the sickest of patients.
Cell-derived exosomes are effective in treating disease when mixed with the dominant protein in breast milk and given orally, a new Smidt Heart Institute study of laboratory mice shows. The findings, published in the peer-reviewed Journal of Extracellular Vesicles, could help develop new oral medications for treating patients with muscular dystrophy and heart failure.
The first wave of Cedars-Sinai staff members are receiving the much-anticipated COVID-19 vaccine Thursday morning, an occasion that is bringing hope and relief to those who have fought on the medical frontline for nearly a year against the deadly illness.
In a year rocked by the COVID-19 (coronavirus) pandemic, the Cedars-Sinai Comprehensive Transplant Center is on track to match or break records.
Just moments after Calabasas ninth grader Oliver Merlob was born, he was whisked away for open-heart surgery to treat a congenital heart defect. Little did his parents know it would be the beginning of a lifelong relationship.
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.
The Smidt Heart Institute at Cedars-Sinai has established a specialized cardiac clinic to care for COVID-19 survivors who may be subject to long-term heart damage. Experts available for interviews in English and Spanish; HD video is available upon request.
Three years after the ALLSTAR clinical trial ended prematurely, the study’s data shows that treatments of cardiosphere-derived cells — the same cells used as an experimental therapy tested in COVID-19 patients — demonstrated unexpected promise in heart attack survivors. Downloadable video available.